70 results
Page 2 of 4
8-K
EX-99.1
7fjsd97cch52 np
11 Aug 22
Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
nvyvuf
13 Jul 22
Agile Therapeutics Updates Second Quarter 2022 Guidance
5:20pm
424B4
fvu7u9faamfr4fe45a
5 Jul 22
Prospectus supplement with pricing info
4:26pm
8-K
EX-99.1
820455w1xb r9
24 May 22
Departure of Directors or Certain Officers
7:30am
8-K
utzyky83
24 May 22
Departure of Directors or Certain Officers
7:30am
8-K
6vagkzn7 e8vg6lf61
23 May 22
Departure of Directors or Certain Officers
8:00am
8-K
EX-99.1
915r sq2m9f98tt1r5
12 May 22
Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
pw5xowqi
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
424B5
1du81zy3swi
27 Apr 22
Prospectus supplement for primary offering
6:30am
8-K
EX-99.1
xwrnqdnaqmsqccau
30 Mar 22
Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update
4:19pm
424B5
jhrwncyn3i6hri
14 Mar 22
Prospectus supplement for primary offering
5:26pm
8-K
gm8 gid58rfibkw
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
EX-99.1
jt7lx80ul
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
424B5
8io84czpzicf3g9k
10 Jan 22
Prospectus supplement for primary offering
8:00am